Cargando…

Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice

INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Daniel, Cuypers, Fabian, Skorka, Sebastian B., Rockstroh, Jan, Gesell Salazar, Manuela, Krieger, Jakob, Albrecht, Dirk, Völker, Uwe, Hammerschmidt, Sven, Lalk, Michael, Siemens, Nikolai, Methling, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185708/
https://www.ncbi.nlm.nih.gov/pubmed/35687250
http://dx.doi.org/10.1007/s11306-022-01898-4
_version_ 1784724777714319360
author Schultz, Daniel
Cuypers, Fabian
Skorka, Sebastian B.
Rockstroh, Jan
Gesell Salazar, Manuela
Krieger, Jakob
Albrecht, Dirk
Völker, Uwe
Hammerschmidt, Sven
Lalk, Michael
Siemens, Nikolai
Methling, Karen
author_facet Schultz, Daniel
Cuypers, Fabian
Skorka, Sebastian B.
Rockstroh, Jan
Gesell Salazar, Manuela
Krieger, Jakob
Albrecht, Dirk
Völker, Uwe
Hammerschmidt, Sven
Lalk, Michael
Siemens, Nikolai
Methling, Karen
author_sort Schultz, Daniel
collection PubMed
description INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Both substance classes possess immunomodulatory functions. However, little is known about their role in respiratory infections. OBJECTIVES: Here, we aimed to analyze the lipid mediator imprint of different organs of C57BL/6J mice after intranasal mono-infections with Streptococcus pneumoniae (pneumococcus), Staphylococcus aureus or Influenza A virus (IAV) as wells as pneumococcal-IAV co-infection. METHODS: C57BL/6J mice were infected with different pathogens and lungs, spleen, and plasma were collected. Lipid mediators were analyzed using HPLC-MS/MS. In addition, spatial-distribution of sphingosine 1-phosphate (S1P) and ceramide 1-phosphates (C1P) in tissue samples was examined using MALDI-MS-Imaging. The presence of bacterial pathogens in the lung was confirmed via immunofluorescence staining. RESULTS: We found IAV specific changes for different HDHAs and HETEs in mouse lungs as well as enhanced levels of 20-HETE in severe S. aureus infection. Moreover, MALDI-MS-Imaging analysis showed an accumulation of C1P and a decrease of S1P during co-infection in lung and spleen. Long chain C1P was enriched in the red and not in the white pulp of the spleen. CONCLUSIONS: Lipid mediator analysis showed that host synthesis of bioactive lipids is in part specific for a certain pathogen, in particular for IAV infection. Furthermore, MS-Imaging displayed great potential to study infections and revealed changes of S1P and C1P in lungs and spleen of co-infected animals, which was not described before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01898-4.
format Online
Article
Text
id pubmed-9185708
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91857082022-06-10 Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice Schultz, Daniel Cuypers, Fabian Skorka, Sebastian B. Rockstroh, Jan Gesell Salazar, Manuela Krieger, Jakob Albrecht, Dirk Völker, Uwe Hammerschmidt, Sven Lalk, Michael Siemens, Nikolai Methling, Karen Metabolomics Original Article INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Both substance classes possess immunomodulatory functions. However, little is known about their role in respiratory infections. OBJECTIVES: Here, we aimed to analyze the lipid mediator imprint of different organs of C57BL/6J mice after intranasal mono-infections with Streptococcus pneumoniae (pneumococcus), Staphylococcus aureus or Influenza A virus (IAV) as wells as pneumococcal-IAV co-infection. METHODS: C57BL/6J mice were infected with different pathogens and lungs, spleen, and plasma were collected. Lipid mediators were analyzed using HPLC-MS/MS. In addition, spatial-distribution of sphingosine 1-phosphate (S1P) and ceramide 1-phosphates (C1P) in tissue samples was examined using MALDI-MS-Imaging. The presence of bacterial pathogens in the lung was confirmed via immunofluorescence staining. RESULTS: We found IAV specific changes for different HDHAs and HETEs in mouse lungs as well as enhanced levels of 20-HETE in severe S. aureus infection. Moreover, MALDI-MS-Imaging analysis showed an accumulation of C1P and a decrease of S1P during co-infection in lung and spleen. Long chain C1P was enriched in the red and not in the white pulp of the spleen. CONCLUSIONS: Lipid mediator analysis showed that host synthesis of bioactive lipids is in part specific for a certain pathogen, in particular for IAV infection. Furthermore, MS-Imaging displayed great potential to study infections and revealed changes of S1P and C1P in lungs and spleen of co-infected animals, which was not described before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01898-4. Springer US 2022-06-10 2022 /pmc/articles/PMC9185708/ /pubmed/35687250 http://dx.doi.org/10.1007/s11306-022-01898-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schultz, Daniel
Cuypers, Fabian
Skorka, Sebastian B.
Rockstroh, Jan
Gesell Salazar, Manuela
Krieger, Jakob
Albrecht, Dirk
Völker, Uwe
Hammerschmidt, Sven
Lalk, Michael
Siemens, Nikolai
Methling, Karen
Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title_full Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title_fullStr Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title_full_unstemmed Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title_short Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
title_sort bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185708/
https://www.ncbi.nlm.nih.gov/pubmed/35687250
http://dx.doi.org/10.1007/s11306-022-01898-4
work_keys_str_mv AT schultzdaniel bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT cuypersfabian bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT skorkasebastianb bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT rockstrohjan bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT gesellsalazarmanuela bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT kriegerjakob bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT albrechtdirk bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT volkeruwe bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT hammerschmidtsven bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT lalkmichael bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT siemensnikolai bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice
AT methlingkaren bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice